Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 19, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Extraction and Purification of Delta-9-THC For Use in MedChew RX Clinical Program

NEW YORK, June 19, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States...
January 23, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients

NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), the world leader in cannabinoid research and development, announced today that it has successfully completed an...
April 13, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard

NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
November 16, 2016 09:00 ET | Source: AXIM Biotechnologies, Inc

New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products

NEW YORK, Nov. 16, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in hemp cannabinoid research and development, today announced that the United...
November 03, 2016 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&D

NEW YORK, Nov. 03, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has published a...
October 26, 2016 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple Indications

NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company has...
September 19, 2016 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa Pharmaceuticals

RAFA to Distribute Axim’s Award-Winning Cannabinoid Chewing Gum CanChew®NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), an innovative biotechnology company...
February 18, 2016 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Leads Cannabis Industry in Cannabinoid Research, Development and Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure

NEW YORK, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) shares the hemp innovator’s vision and...
January 13, 2016 09:15 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Featured in Marijuana Documentary “Cannabis is Medicine”

NEW YORK, Jan. 13, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) is pleased to announce that the Company’s efforts on clinical development of a patented cannabinoid-based medical...
October 30, 2015 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Secures Land Down Payment for Hemp Life Sciences Manufacturing Site

NEW YORK, Oct. 30, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce that it has secured the down payment on land to build the Company’s manufacturing...

Next Page keyboard_arrow_right